Account
Inquiry
QSC Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist developed for research applications in metabolic disorders. This synthetic peptide analog shares structural similarities with human GLP-1 and has demonstrated potential in various preclinical studies.
The QSC Semaglutide compound exhibits extended half-life characteristics compared to native GLP-1, making it particularly valuable for research purposes. Its mechanism of action involves glucose-dependent stimulation of insulin secretion while suppressing glucagon secretion.
Our QSC Semaglutide is produced under strict GMP conditions with comprehensive quality control measures. Each batch undergoes rigorous analytical testing including HPLC, MS, and amino acid analysis to ensure purity and structural integrity.
Key research applications include: investigation of glycemic control mechanisms, obesity-related metabolic studies, and potential cardiovascular effects. The peptide has shown particular interest in studies examining sustained receptor activation and prolonged metabolic effects.
Note: This product is intended for research purposes only. Not for human or veterinary use.
